Healing Thresholds - Connecting Community and Science to Heal Autism

atomoxetine

Co-Occurrence of ADHD and Autism Spectrum Disorders: Phenomenology and Treatment Reiersen, A.; Todd, R. , Expert Rev Neurotherapeutics, Volume 8, Issue 4, p.657-669, (2008) Layperson Summary

Open-Label Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms Associated with High-Functioning Pervasive Developmental Disorders Posey, D.; Weigand, R.; Wilkerson, J.; Maynard, M.; Stigler, K.; McDougle, C. , Journal of Child and Adolescent Psychopharmacology, Volume 16, Issue 5, p.599-610, (2006) Layperson Summary

Atomoxatine for Attention-Deficit/Hyperactivity Disorder Symptoms in Children with Pervasive Developmental Disorders: A Pilot Study Troost, P.; Steenhuis, M.; Tuynman-Qua, H.; Kalverdijk, L.; Buitelaar, J.; Minderaa, R.; Hoekstra, P. , Journal of Child and Adolescent Psychopharmacology, Volume 16, Issue 5, p.611-619, (2006) Layperson Summary

Atomoxetine: Treating Patients with Autistic Disorder Niederhofer, H. , Autism, Volume 10, Issue 6, p.647-650, (2006) Layperson Summary

Atomoxetine for Hyperactivity in Autism Spectrum Disorders: Placebo-Controlled Crossover Pilot Trial Arnold, L.; Cook, M.; Witwer, A.; Hall, K.; Thompson, S.; Ramadan, Y. , J. Am. Acad. Child Adolesc., Volume 45, Issue 10, p.1196-1205, (2006) Layperson Summary